In cancer, virtually all genomic breakpoints leading to ALK chimeras are located within the intron between exons 19 and 20 (NM_004304.3), leading to the fusion of the intracytoplasmic domain of ALK (exons 20–29) with different partners, which provide dimerization domains (10, 17, 18). This evidence concerns the gene ALK and cancer.